POINT 1 Study
Install Now
POINT 1 Study
POINT 1 Study

POINT 1 Study

Developer: Parallel 6, Inc.
App Size: 40.6 MB
Release Date: 2017-09-27
Price: FREE
Price
FREE
Size
40.6 MB

Screenshots for App

iPhone
iPad
More Screenshots for iPad
"Please Note: This app is only for use by those participating in this study. The POINT 1 Study is a two part pediatric
study of Afrezza inhaled human insulin in pediatric patients with type 1 diabetes mellitus.

The POINT 1 Study App is a tool for for enrolled patients to manage and understand study participation."
Show More
Show Less
POINT 1 Study 0.3.26 Update
This app has been updated by Apple to use the latest Apple signing certificate.1. Removed bluetooth option for Glucometer reading transfer2. Added logic into the app where if a Glucose reading of less than 70mg/dl (Hypoglycemic Event), it automatically redirects you to symptom reporting screens.

~Parallel 6, Inc.
More Information about: POINT 1 Study
Price: FREE
Version: 0.3.26
Compatibility: Requires Requires iOS 9 or later
Bundle Id: com.parallel6.mannkindafrezzapatient
Size: 40.6 MB
Genre: Medical
Release Date: 2017-09-27
Last Update:
Content Rating: 12+
Developer: Parallel 6, Inc.
Language: English -


Whatsapp
Vkontakte
Telegram
Reddit
Pinterest
Linkedin
Hide